PROFOUND MEDICAL CORP (PRN.CA) Stock Analyst Earnings Estimates
TSX:PRN - Toronto Stock Exchange - CA74319B5027 - Common Stock - Currency: CAD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 6.873M -5.90% | 6.681M -2.79% | 7.199M 7.75% | 11.271M 56.56% | 28.327M 151.33% | 55.787M 96.94% | 92.785M 66.32% | 154.81M 66.85% | 174.77M 12.89% | 228.03M 30.47% | |
| EBITDA YoY % growth | -28.412M -63.99% | -27.998M 1.46% | -27.47M 1.89% | -25.871M 5.82% | -19.249M 25.60% | 4.901M 125.46% | 25.307M 416.36% | 63.547M 151.10% | 66.408M 4.50% | 98.704M 48.63% | |
| EBIT YoY % growth | -30.291M -60.58% | -29.602M 2.27% | -28.616M 3.33% | -33.734M -17.89% | -32.522M 3.59% | -20.335M 37.47% | -482.237K 97.63% | 30.162M 6,354.59% | 9.432M -68.73% | 32.464M 244.19% | |
| Operating Margin | -440.72% | -443.08% | -397.50% | -299.30% | -114.81% | -36.45% | -0.52% | 19.48% | 5.40% | 14.24% | |
| EPS YoY % growth | -1.50 -22.86% | -1.38 8.00% | -1.35 2.17% | -1.20 17.04% | -0.91 19.06% | -0.71 21.63% | 0.28 140.08% | 1.41 394.32% | 1.77 26.10% | 2.76 55.62% |
All data in USD
| Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|
| EPS Q2Q % growth | -0.29 -10.71% | -0.27 4.41% | -0.21 44.18% | -0.17 14.15% |
| Revenue Q2Q % growth | 5.252M 174.97% | 6.414M 187.24% | 9.595M 238.81% | 11.918M 185.12% |
| EBITDA Q2Q % growth | -6.161M 14.16% | -5.05M 30.26% | 404K 104.97% | 2.727M 135.06% |
| EBIT Q2Q % growth | -8.989M -20.14% | -8.383M -7.02% | -6.717M 25.27% | -5.353M 41.76% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2024 Q2Q % growth | -0.20 52.38% | -0.34 | 0.14 | 40.59% |
| Q3 2024 Q2Q % growth | -0.38 -46.15% | -0.30 | -0.08 | -28.63% |
| Q2 2024 Q2Q % growth | -0.28 20.00% | -0.29 | 0.01 | 5.06% |
| Q1 2024 Q2Q % growth | -0.26 18.75% | -0.28 | 0.02 | 6.39% |
| Q4 2023 Q2Q % growth | -0.42 8.70% | -0.32 | -0.10 | -30.15% |
| Q3 2023 Q2Q % growth | -0.26 -8.33% | -0.34 | 0.08 | 23.48% |
| Q2 2023 Q2Q % growth | -0.35 -25.00% | -0.36 | 0.01 | 2.34% |
| Q1 2023 Q2Q % growth | -0.32 20.00% | -0.36 | 0.04 | 11.99% |
| Q4 2022 Q2Q % growth | -0.46 6.12% | -0.37 | -0.09 | -23.09% |
| Q3 2022 Q2Q % growth | -0.24 17.24% | -0.37 | 0.13 | 35.19% |
| Q2 2022 Q2Q % growth | -0.28 20.00% | -0.40 | 0.12 | 29.52% |
| Q1 2022 Q2Q % growth | -0.40 -8.11% | -0.46 | 0.06 | 13.90% |
| Q4 2021 Q2Q % growth | -0.49 -28.94% | -0.34 | -0.15 | -45.55% |
| Q3 2021 Q2Q % growth | -0.29 10.17% | -0.27 | -0.02 | -8.35% |
| Q2 2021 Q2Q % growth | -0.35 -5.43% | -0.29 | -0.06 | -20.88% |
| Q1 2021 Q2Q % growth | -0.37 -98.84% | -0.27 | -0.10 | -39.15% |
| Q4 2020 Q2Q % growth | -0.38 -11.44% | -0.31 | -0.07 | -24.05% |
| Q3 2020 Q2Q % growth | -0.32 25.23% | -0.25 | -0.08 | -31.30% |
| Q2 2020 Q2Q % growth | -0.33 11.19% | -0.22 | -0.11 | -48.16% |
| Q1 2020 Q2Q % growth | -0.19 17.54% | -0.26 | 0.08 | 29.29% |
| Q4 2019 Q2Q % growth | -0.34 | -0.49 | 0.15 | 31.00% |
| Q3 2019 Q2Q % growth | -0.43 | -0.39 | -0.04 | -11.34% |
| Q2 2019 Q2Q % growth | -0.37 | -0.34 | -0.03 | -10.00% |
| Q1 2019 Q2Q % growth | -0.23 | -0.34 | 0.11 | 33.60% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2024 Q2Q % growth | 4.18M 108.06% | 4.175M | 4.999K | 0.12% |
| Q3 2024 Q2Q % growth | 2.832M 63.89% | 2.91M | -78K | -2.68% |
| Q2 2024 Q2Q % growth | 2.233M 39.39% | 2.417M | -184K | -7.61% |
| Q1 2024 Q2Q % growth | 1.91M 2.69% | 2.82M | -910K | -32.27% |
| Q4 2023 Q2Q % growth | 2.009M 59.82% | 1.997M | 12K | 0.60% |
| Q3 2023 Q2Q % growth | 1.728M -15.09% | 2.087M | -359K | -17.20% |
| Q2 2023 Q2Q % growth | 1.602M -20.89% | 2.158M | -556K | -25.76% |
| Q1 2023 Q2Q % growth | 1.86M 36.36% | 2.238M | -378K | -16.89% |
| Q4 2022 Q2Q % growth | 1.257M 25.95% | 2.962M | -1.705M | -57.56% |
| Q3 2022 Q2Q % growth | 2.035M -19.79% | 2.224M | -189K | -8.50% |
| Q2 2022 Q2Q % growth | 2.025M -22.92% | 1.818M | 207K | 11.39% |
| Q1 2022 Q2Q % growth | 1.364M 91.84% | 2.19M | -826K | -37.72% |
| Q4 2021 Q2Q % growth | 998K -65.34% | 2.592M | -1.594M | -61.50% |
| Q3 2021 Q2Q % growth | 2.537M 13.36% | 3.886M | -1.349M | -34.71% |
| Q2 2021 Q2Q % growth | 2.627M 156.04% | 2.236M | 391K | 17.49% |
| Q1 2021 Q2Q % growth | 711K -38.71% | 2.612M | -1.901M | -72.78% |
| Q4 2020 Q2Q % growth | 2.879M 35.98% | 2.271M | 608.4K | 26.79% |
| Q3 2020 Q2Q % growth | 2.238M 333.05% | 1.837M | 401K | 21.83% |
| Q2 2020 Q2Q % growth | 1.026M 138.99% | 749.309K | 276.691K | 36.93% |
| Q1 2020 Q2Q % growth | 1.16M 4.47% | 882.023K | 277.977K | 31.52% |
| Q4 2019 Q2Q % growth | 2.118M | 2.073M | 44.5K | 2.15% |
| Q3 2019 Q2Q % growth | 516.8K | 1.179M | -662.2K | -56.17% |
| Q2 2019 Q2Q % growth | 429.3K | 983.316K | -554.016K | -56.34% |
| Q1 2019 Q2Q % growth | 1.11M | 780.972K | 329.428K | 42.18% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -4.99% | -1.06% | -1.92% |
| Revenue | 0% | -0.78% | 0% | -0.03% |